RIBOPRO

We are happy to announce that RIBOPRO will be sponsoring and exhibiting at the FIGON Dutch Medicine Days (DMD) from October 16-17 at the Theatre de Lievekamp in Oss, Netherlands. DMD is the conference where partners from industry, scientific and professional associations, universities, business and government can present their findings, share new scientific content and strengthen their network. Our team is eager to share insights on how RIBOPRO is advancing the future of mRNA and LNP based medicines through our pioneering research and development. We look forward to connecting with you and exploring new possibilities together. Don’t miss out on this opportunity to learn more about how RIBOPRO is making a difference in the world of mRNA. See you at the FIGON Dutch Medicine Days! #RIBOPRO #FigonDutchMedicineDays #Innovation #Biotechnology #Healthcare #LifeSciences #DrugDevelopment #FutureOfMedicine

We are pleased to share how our fluorescent labelled mRNA played a role in a research study titled “Unravelling mRNA Delivery Bottlenecks of Ineffective Delivery Vectors by Cotransfection with Effective Carriers”. In this study, Oude Egberink et al. has made significant strides in overcoming the challenges of mRNA delivery. By cotransfecting ineffective delivery vectors with effective carriers, they’ve identified key strategies to enhance the efficiency and effectiveness of mRNA delivery. This research holds the potential to greatly enhance the effectiveness of mRNA-based gene therapies and vaccine development by overcoming key delivery challenges. 💉🔬 This collaboration underscores our commitment to supporting pioneering research and innovation. We are proud to contribute to advancements that push the boundaries of knowledge and technology. A huge congratulations to the research team for their outstanding work! 🎉👏 🔗 Read the full article here: https://lnkd.in/extUPihr #Innovation #Research #mRNATechnology #Science #ProudMoment #OurProductsInAction

 🧬mRNA Insider - Week 37   Your weekly update in the field of mRNA & delivery!   If you have any questions about mRNA or mRNA formulations in LNPs, feel free to contact us: https://lnkd.in/dyfmHhVg.   References 1. Banik et al. 2024 https://lnkd.in/emb9WDC4 2. Shan et al. 2024 https://lnkd.in/euCZyi8P 3. Wu et al. 2024 https://lnkd.in/eCUut3Sk

We are pleased to share how our custom mRNA played a role in a study titled “Lipid-based transfection of zebrafish embryos: a robust protocol for nucleic acid delivery”. The study presents a reliable method for delivering nucleic acids into zebrafish embryos using lipid-based transfection. Their protocol bypasses the need for microinjection, offering a cost-effective, high throughput, and user-friendly alternative. It outlines new strategies for gene delivery in zebrafish to enhance the efficiency and scope of genetic studies in this model system. This collaboration underscores our commitment to supporting pioneering research and innovation. We are proud to contribute to advancements that push the boundaries of knowledge and technology. A huge congratulations to the research team for their outstanding work! 🎉👏 🔗 https://lnkd.in/e8pvFpbh #Innovation #Research #mRNATechnology #Science #Proudmoment #OurProductsInAction

🧬mRNA Insider - Week 35   This weeks mRNA insider discusses the critical role of LNPs in delivering mRNA therapeutics, highlighting recent advancements in LNP engineering to enhance non-liver targeting and discusses the impact of mixing and shaking on mRNA-LNP drug quality.   If you have any questions about mRNA or mRNA formulations in LNPs, feel free to contact us: https://lnkd.in/dyfmHhVg.   References 1. Saber et al. 2024 https://lnkd.in/d7NETeQj 2. Matthessen et al. 2024 https://lnkd.in/eBufsYtQ 3. Wang et al. 2024 https://lnkd.in/dt3nQnYC

We are pleased to share how our custom mRNA played a role in a research study titled “mRNA-delivered consensus allergens induce a neutralizing IgG response against food and pollen allergens”. The study explores the innovative use of mRNA technology to induce a neutralizing IgG response, offering promising advancements in allergy treatment for patients with Pollen-food allergy syndrome (PFAS). This collaboration underscores our commitment to supporting pioneering research and innovation. We are proud to contribute to advancements that push the boundaries of knowledge and technology. A huge congratulations to the research team for their outstanding work! 🎉👏 🔗 https://lnkd.in/e4JNqCN2 #Innovation #Research #mRNATechnology #Science #ProudMoment #OurProductsInAction

🧬mRNA Insider - Week 34   Your weekly update in the field of mRNA & delivery!   If you have any questions about mRNA or mRNA formulations in LNPs, feel free to contact us: https://lnkd.in/dyfmHhVg.   References 1. Barbieri et al. 2024 https://lnkd.in/eAqPdWX2 2. Biziaev et al. 2024 https://lnkd.in/ehhNUwgF 3. Chen et al. 2024 https://lnkd.in/e9kX_NpM

🧬mRNA Insider - Week 33   Your weekly update in the field of mRNA & delivery!   If you have any questions about mRNA or mRNA formulations in LNPs, feel free to contact us: https://lnkd.in/dyfmHhVg.   References 1. Mamaghani et al. 2024 https://lnkd.in/eNcS_sni 2. Tadic et al. 2024 https://lnkd.in/eUhmvmYw 3. Bai et al. 2024 https://lnkd.in/e_qCwUdH

  🧬mRNA Insider - Week 32   Another week of progress in the field of mRNA and LNPs!   If you have any questions about mRNA or mRNA formulations in LNPs, feel free to contact us: https://lnkd.in/dyfmHhVg.   References 1. Tadic et al. 2024 https://lnkd.in/eUhmvmYw 2. Couture-Senécal et al. 2024 https://lnkd.in/eMG62xTx 3. Guenaga et al. 2024 https://lnkd.in/e-v9UY_M

 🧬mRNA Insider - Week 31   Your weekly update in the field of mRNA & delivery!   If you have any questions about mRNA or mRNA formulations in LNPs, feel free to contact us: https://lnkd.in/dyfmHhVg.   References 1. Kuzminich et al. 2024 https://lnkd.in/emuWaWph 2. Ole Sti Dahl et al. 2024 https://lnkd.in/eqCkPp-H 3. Palanki et al. 2024 https://lnkd.in/ecmR268P